Related references
Note: Only part of the references are listed.Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening
Dorien C. Rijkaart et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial
Dorien C. Rijkaart et al.
LANCET ONCOLOGY (2012)
Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study
Veronika Ucakar et al.
VACCINE (2012)
The Biology and Life-Cycle of Human Papillomaviruses
John Doorbar et al.
VACCINE (2012)
Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland
Maarit K. Leinonen et al.
BRITISH MEDICAL JOURNAL (2012)
Genotyping of human papillomavirus in triaging of low-grade cervical cytology
Anna Soderlund-Strand et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia
Elena Shipitsyna et al.
CANCER EPIDEMIOLOGY (2011)
Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice
Walter Kinney et al.
GYNECOLOGIC ONCOLOGY (2011)
Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication
Ni Li et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2011)
Population fraction of cervical neoplasia attributable to high-risk human papillomaviruses
Paivi Laukkanen et al.
FUTURE ONCOLOGY (2010)
What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?
Warner Huh et al.
GYNECOLOGIC ONCOLOGY (2010)
Optimal Threshold for a Positive Hybrid Capture 2 Test for Detection of Human Papillomavirus: Data from the ARTISTIC Trial
A. Sargent et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings
Laia Bruni et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection
Ana Cecilia Rodriguez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
Susanne K. Kjaer et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose et al.
LANCET ONCOLOGY (2010)
Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium
Marc Arbyn et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Prevalence and distribution of high-risk human papillomavirus in Greece
Theodoros Agorastos et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2009)
Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus
Anna Soederlund-Strand et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting
Maarit Leinonen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening
Pontus Naucler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
V. M. H. Coupe et al.
BRITISH JOURNAL OF CANCER (2008)
Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland
A. Bardin et al.
EUROPEAN JOURNAL OF CANCER (2008)
Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3
Laura Kota Niemi-Talonen et al.
EUROPEAN JOURNAL OF CANCER (2008)
Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark
Susanne K. Kjaer et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Human papillomavirus genotype specificity of Hybrid Capture 2
Philip E. Castle et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries
Jack Cuzick et al.
VACCINE (2008)
Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joalim Dillner et al.
BRITISH MEDICAL JOURNAL (2008)
Preservation of DNA
Thomas J. Anchordoquy et al.
CELL PRESERVATION TECHNOLOGY (2007)
Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update
Jennifer S. Smith et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology:: a meta-analysis
Silvia de Sanjose et al.
LANCET INFECTIOUS DISEASES (2007)
HPV type-specific risks of high-grade CIN during 4 years of follow-up:: A population-based prospective study
P. Naucler et al.
BRITISH JOURNAL OF CANCER (2007)
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality
Melinda Butsch Kovacic et al.
CANCER RESEARCH (2006)
Clinical utility of HPV genotyping
Chris J. Meijer et al.
GYNECOLOGIC ONCOLOGY (2006)
Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+PCR method in a population-based cervical screening program
A. T. Hesselink et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Bead-based multiplex genotyping of human papillomaviruses
M Schmitt et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice
MJ Khan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
The carcinogenicity of human papillornavirus types reflects viral evolution
M Schiffman et al.
VIROLOGY (2005)
Biological sample collection and processing for molecular epidemiological studies
NT Holland et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis
ME Sherman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Population-based type-specific prevalence of high-risk human papillomavirus infection in middle-aged Swedish women
O Forslund et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Share Paper
